Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 4Lymphoma 2Thymoma 1Neuroendocrine Tumors 1Lymphoma, Non-Hodgkin 1Leukemia 1Histiocytosis, Sinus 1Erdheim-Chester Disease 1

Interventions

fludarabine 1Transplantation 1Tablets 1Stem Cell Transplantation 1Roflumilast 1Pemetrexed 1Nadolol 1Isoproterenol 1Introns 1FANG vaccine 1Exercise 1Cyclophosphamide 1Counseling 1Cord Blood Stem Cell Transplantation 1Carvedilol 1Bortezomib 1Bisoprolol 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia × 68Ga-pentixafor × Clear all
NCT04504526 2023-09-15

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Unknown
50 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡